Jon S. Saxe
CIK: 0001114914
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VTGN
Vistagen Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About SAXE JON S
SAXE JON S (SEC CIK 0001114914) files insider reports with the SEC as Director of Vistagen Therapeutics, Inc. (VTGN).
Signal8 holds 2 ownership filings by SAXE JON S, all Form 4s, filed between Sep 10, 2024 and Sep 11, 2025. Those filings report 2 transactions, from Sep 6, 2024 to Sep 9, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on SAXE JON S's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by SAXE JON S
Other insiders filing for Vistagen Therapeutics, Inc. (VTGN)
- Williamson Douglas J, Officer
- Adler Reid G., Chief Legal Officer
- Tressler Nick B., Chief Financial Officer
- Singh Shawn, President and CEO
- Angelov Angel S, Chief Medical Officer
- Prince Joshua S., Chief Operating Officer